Chimerix Inc CMRX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.95
- Day Range
- $0.95–0.96
- 52-Week Range
- $0.89–2.40
- Bid/Ask
- $0.91 / $0.99
- Market Cap
- $85.73 Mil
- Volume/Avg
- 100,561 / 469,941
Key Statistics
- Price/Earnings (Normalized)
- 21.66
- Price/Sales
- 74.05
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 89
- Website
- https://www.chimerix.com
Valuation
|
Metric
|
CMRX
|
|---|---|
Price/Earnings (Normalized) | 21.66 |
Price/Book Value | 0.41 |
Price/Sales | 74.05 |
Price/Cash Flow | — |
Price/Earnings
CMRX
Financial Strength
|
Metric
|
CMRX
|
|---|---|
Quick Ratio | 12.54 |
Current Ratio | 12.94 |
Interest Coverage | — |
Quick Ratio
CMRX
Profitability
|
Metric
|
CMRX
|
|---|---|
Return on Assets (Normalized) | −25.25% |
Return on Equity (Normalized) | −27.23% |
Return on Invested Capital (Normalized) | −31.58% |
Return on Assets
CMRX
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Dhz | $450.9 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Mlhcvg | $89.4 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Hsmfnv | $87.3 Bil | |
SGEN
| Seagen Inc Ordinary Shares | Nmysh | $40.4 Bil | |
MRNA
| Moderna Inc | Xygk | $29.8 Bil | |
ARGX
| argenx SE ADR | Pjpq | $26.4 Bil | |
BNTX
| BioNTech SE ADR | Npxb | $23.4 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Bjsrdp | $20.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Llpfgn | $16.5 Bil | |
INCY
| Incyte Corp | Skdcns | $11.8 Bil |